Company / Shareholders' Equity
PRECISION BIOSCIENCES INC Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$56.4M
FY2025
5-year range
$18.9M / $91.2M
FY2021-FY2025
Trend
+199.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity returned to growth in FY2025 after 2 years of decline, reaching $56M.
Based on SEC 10-K filings.
$56M in FY2025 with a 5-year CAGR of -16.4%.
Declined from $60M to $56M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -16.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.4%, indicating a declining trend.
- In FY2025, shareholders' equity increased 199.0% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.4M | +199.0% |
| FY2024 | $18.9M | -68.8% |
| FY2023 | $60.4M | -33.7% |
| FY2022 | $91.2M | +105.2% |
| FY2021 | $44.4M | -67.9% |
| FY2020 | $138.3M | +246.1% |
| FY2019 | $40.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026